hurn
Huron Consulting Group Inc. (NASDAQ: HURN) is the worst performer on earnings restatements and management being replaced. Repros Therapeutics (NASDAQ: RPRX) is down sharply by over 50% after stopping trials on patient safety. Huron Consulting (NASDAQ:HURN) is getting lots of commentary following news out late Friday as the co disclosed need to restate financials for 2006-2008 and 1Q09 due to accounting errors, withdrew 2009 EPS guidance and lowered revs Huron Consulting Group Inc. (NASDAQ: HURN) is getting destroyed as the worst pre-market stock. UPDATE at 8:25 AM EST: almost 800000 shares have traded hands and shares are down a sharp 69% at $13.70… this will be an exponential volume